AUG 12, 2015 10:06 PM PDT

Brain Receptors Control Behavior

WRITTEN BY: Ilene Schneider
Losing a critical receptor in a special class of inhibitory neurons in the brain may cause neurodevelopmental disorders, such as autism and schizophrenia, according to new research by Salk Institute's Computational Neurobiology Laboratory scientists. While the importance of the receptor, mGluR5, in other areas of the brain had been established, no one had studied its specific role in a cell type known as parvalbumin-positive interneurons. The neurons are considered important in developing general cognition and generating certain types of oscillatory wave patterns in the brain, according to research published in Molecular Psychiatry on August 11, 2015, and reported in Bioscience Technology (http://www.biosciencetechnology.com/news/2015/08/receptors-brain-linked-schizophrenia-autism?et_cid=4736557&et_rid=45505806&type=cta).
Neurodevelopmental disorders can be caused by the loss of a receptor in neurons.
As Terrence Sejnowski, head of Salk's Computational Neurobiology Laboratory, explained, "We found that without this receptor in the parvalbumin cells, mice have many serious behavioral deficits, and a lot of them really mimic closely what we see in schizophrenia."

Scientists had previously discovered that when molecular signaling was disrupted in these cells during development, the brain's networks didn't form correctly. Separate studies have revealed that mGluR5 receptors, which transmit glutamate signaling in the brain, are linked to addiction disorders, anxiety and Fragile X Syndrome. But, in these cases, mGluR5 is affected in excitatory cells, not inhibitory cells like the parvalbumin-positive interneurons.

In 2014 researchers at Washington University in St. Louis concluded that the problems people with autism have with memory formation, higher-level thinking and social interactions may be partially attributable to the activity of receptors inside brain cells. They discovered that the mGlu5 receptor becomes activated when it binds to the neurotransmitter glutamate, which is associated with learning and memory. This leads to chain reactions that convert the glutamate's signal into messages traveling inside the cell (http://www.sciencedaily.com/releases/2014/03/140326141654.htm).

The Salk team questioned the role of mGluR5 in the parvalbumin cells, because the cells were considered so important in brain development. They worked with Athina Markou's team from the Department of Psychiatry at the University of California, San Diego, to examine what occurred when the receptor was "selectively deleted from these cells after the brain's initial formation." They discovered that without the receptor in these cells, mice had numerous developmental problems, including "obsessive, repetitive grooming behavior and anti-social tendencies." Additionally, the patterns of activity in the animals' brains resembled patterns observed in humans suffering from schizophrenia.

"This discovery implies that changes after birth, not just before birth, are affecting the way the network is set up," said Margarita Behrens, corresponding author and Salk staff scientist.

According to Sejnowski, the findings indicate that an alteration in mGluR5 receptors in these brain cells could lead to the formation of some neurodevelopmental disorders. He believes that the molecular change is potentially reversible.

He concluded, "The cells are still alive, and if we can figure out how to go in and change some of these molecular switches, we might actually be able to put the cells back into healthy, functioning states."
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUL 24, 2021
Cannabis Sciences
How Does Cannabis Affect Young People with ADHD?
JUL 24, 2021
How Does Cannabis Affect Young People with ADHD?
Researchers from Stanford University have conducted a review on current research investigating adverse effects on brain ...
JUL 25, 2021
Genetics & Genomics
Understanding How Mitochondrial Dysfunction May Cause Parkinson's
JUL 25, 2021
Understanding How Mitochondrial Dysfunction May Cause Parkinson's
Parkinson's disease is a complex neurodegenerative disorder. While age is a major risk factor, genetics and environmenta ...
AUG 24, 2021
Health & Medicine
Do "brain trainers" make you smarter? Maybe, maybe not.
AUG 24, 2021
Do "brain trainers" make you smarter? Maybe, maybe not.
There is no consensus about the efficacy of online cognitive games, but a recent study found no cognitive improvements a ...
SEP 03, 2021
Technology
Bionic Arm Effective at Restoring "Natural" Arm Function in Amputees
SEP 03, 2021
Bionic Arm Effective at Restoring "Natural" Arm Function in Amputees
A research team at the Cleveland Clinic has developed a new mechanical arm that could help people who have received arm ...
SEP 09, 2021
Drug Discovery & Development
Can vaccines help prevent and treat opioid addiction?
SEP 09, 2021
Can vaccines help prevent and treat opioid addiction?
According to the United States Centers for Disease Control (CDC), 136 people die from an opioid overdose every ...
SEP 24, 2021
Drug Discovery & Development
Nasal Drugs Show Promise for Slowing Parkinson's Disease
SEP 24, 2021
Nasal Drugs Show Promise for Slowing Parkinson's Disease
Two drugs delivered via the nose have shown promise for improving symptoms of Parkinson's disease in mice. The corre ...
Loading Comments...